DK0763010T3 - Enantioselektiv præparering af optisk ren albuterol - Google Patents
Enantioselektiv præparering af optisk ren albuterolInfo
- Publication number
- DK0763010T3 DK0763010T3 DK95919913T DK95919913T DK0763010T3 DK 0763010 T3 DK0763010 T3 DK 0763010T3 DK 95919913 T DK95919913 T DK 95919913T DK 95919913 T DK95919913 T DK 95919913T DK 0763010 T3 DK0763010 T3 DK 0763010T3
- Authority
- DK
- Denmark
- Prior art keywords
- optically pure
- enantioselective preparation
- albuterol
- pure albuterol
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/34—Preparation of optical isomers by separation of optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/247,302 US5399765A (en) | 1994-05-23 | 1994-05-23 | Enantioselective preparation of optically pure albuterol |
US08/376,072 US5545745A (en) | 1994-05-23 | 1995-01-20 | Enantioselective preparation of optically pure albuterol |
PCT/US1995/006539 WO1995032178A1 (en) | 1994-05-23 | 1995-05-23 | Enantioselective preparation of optically pure albuterol |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0763010T3 true DK0763010T3 (da) | 2001-01-08 |
Family
ID=26938588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95919913T DK0763010T3 (da) | 1994-05-23 | 1995-05-23 | Enantioselektiv præparering af optisk ren albuterol |
Country Status (11)
Country | Link |
---|---|
US (1) | US5545745A (da) |
EP (1) | EP0763010B1 (da) |
JP (1) | JP3826208B2 (da) |
AT (1) | ATE195931T1 (da) |
AU (1) | AU686386B2 (da) |
DE (1) | DE69518646T2 (da) |
DK (1) | DK0763010T3 (da) |
ES (1) | ES2151065T3 (da) |
GR (1) | GR3034982T3 (da) |
PT (1) | PT763010E (da) |
WO (1) | WO1995032178A1 (da) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136327A (en) | 1997-12-01 | 2000-10-24 | Alza Corporation | Stereospecific delivery of a drug using electrotransport |
WO1999042460A1 (en) * | 1998-02-20 | 1999-08-26 | Fine Chemicals Corporation (Proprietary) Limited | Process for the production of optically enriched (r)- or (s)-albuterol |
ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
US7232837B2 (en) * | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
US6451289B2 (en) * | 2000-03-24 | 2002-09-17 | Sepracor Inc. | Albuterol formulations |
GB0030171D0 (en) | 2000-12-11 | 2001-01-24 | Cipla Ltd | Process for preparing isomers of salbutamol |
US6596686B2 (en) | 2001-03-12 | 2003-07-22 | International Flavors & Fragrances Inc. | Use of dihydropyrans as fragrance Material |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
DK1572622T3 (da) | 2002-12-10 | 2006-08-28 | Sepracor Inc | Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator |
WO2004101592A1 (ja) * | 2003-05-19 | 2004-11-25 | Taisho Pharmaceutical Co., Ltd. | エリスロマイシンa誘導体の製造方法 |
US20050020692A1 (en) * | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
CA2545559A1 (en) * | 2003-11-20 | 2005-06-09 | Alteragon Pty Ltd. | Method of decreasing fat deposits and body weight in mammals and birds |
US7488758B2 (en) * | 2004-05-20 | 2009-02-10 | Teva Pharmaceutical Fine Chemicals, S.R.L. | Levalbuterol hydrochloride polymorph B |
DE102004054054A1 (de) * | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
RU2440972C2 (ru) * | 2004-12-17 | 2012-01-27 | Сипла Лимитед | Кристаллический сульфат левосальбутамола, способ его получения и фармацевтическая композиция, содержащая его |
KR20070100735A (ko) | 2004-12-17 | 2007-10-11 | 씨아이피엘에이 엘티디. | 약학적 화합물 및 조성물 |
EP1832572A1 (en) * | 2006-03-08 | 2007-09-12 | Stirling Products Limited | Process for the enantiomeric enrichment of salbutamol and salbutamol precursors |
CA2810839A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
US8063251B2 (en) | 2006-08-02 | 2011-11-22 | Aarti Healthcare Limited | Process for the preparation of optically pure R (−) salbutamol and its pharmaceutically acceptable salts |
EP1935872A1 (en) * | 2006-12-11 | 2008-06-25 | Stirling Products Limited | Process for obtaining the R-enantiomer of salbutamol |
AU2008331928B2 (en) * | 2007-12-03 | 2012-08-16 | Bridge Pharma, Inc. | Use of RR/SR-ractopamine |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
WO2010047717A1 (en) * | 2008-10-24 | 2010-04-29 | Biolink Life Sciences, Inc. | Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
AU2009331471B2 (en) | 2008-12-23 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Salt forms of organic compound |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
CA2803504C (en) | 2010-06-24 | 2022-08-30 | Boehringer Ingelheim International Gmbh | A combination for diabetes therapy comprising linagliptin and a long-acting insulin |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
DK2731947T3 (da) | 2011-07-15 | 2019-04-23 | Boehringer Ingelheim Int | Substitueret dimerisk quinazolin-derivat, fremstilling og andvendelse deraf i farmaceutiske sammensætninger til behandling af type i- og type ii-diabetes |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
EP2849755A1 (en) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
WO2015023816A1 (en) * | 2013-08-15 | 2015-02-19 | Allergan, Inc. | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
JP6615109B2 (ja) | 2014-02-28 | 2019-12-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Dpp−4阻害薬の医学的使用 |
EP3042892A1 (en) | 2015-01-09 | 2016-07-13 | Deva Holding Anonim Sirketi | Amorphisation of levosalbutamol tartrate |
WO2017211979A1 (en) | 2016-06-10 | 2017-12-14 | Boehringer Ingelheim International Gmbh | Combinations of linagliptin and metformin |
KR20230081285A (ko) * | 2021-11-30 | 2023-06-07 | 주식회사 브이에스팜텍 | 고순도의 1-(1-(2-벤질페녹시)프로판-2-일)-2-메틸피페리딘 단일 이성질체의 제조방법 |
CN115286521B (zh) * | 2022-07-11 | 2023-11-03 | 上海医药集团(本溪)北方药业有限公司 | 一种盐酸左沙丁胺醇的合成方法 |
CN116693406B (zh) * | 2023-06-02 | 2024-04-19 | 山东锐顺药业有限公司 | 一种硫酸沙丁胺醇的制备方法 |
CN116836069B (zh) * | 2023-06-02 | 2024-01-30 | 山东锐顺药业有限公司 | 一种盐酸左沙丁胺醇的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119477A (en) * | 1990-09-11 | 1999-10-28 | Schering Corp | Process for preparing glyoxal hydrates |
-
1995
- 1995-01-20 US US08/376,072 patent/US5545745A/en not_active Expired - Lifetime
- 1995-05-23 ES ES95919913T patent/ES2151065T3/es not_active Expired - Lifetime
- 1995-05-23 AU AU25559/95A patent/AU686386B2/en not_active Expired
- 1995-05-23 PT PT95919913T patent/PT763010E/pt unknown
- 1995-05-23 DE DE69518646T patent/DE69518646T2/de not_active Expired - Lifetime
- 1995-05-23 WO PCT/US1995/006539 patent/WO1995032178A1/en active IP Right Grant
- 1995-05-23 DK DK95919913T patent/DK0763010T3/da active
- 1995-05-23 EP EP95919913A patent/EP0763010B1/en not_active Expired - Lifetime
- 1995-05-23 JP JP53051395A patent/JP3826208B2/ja not_active Expired - Lifetime
- 1995-05-23 AT AT95919913T patent/ATE195931T1/de active
-
2000
- 2000-11-24 GR GR20000402605T patent/GR3034982T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU686386B2 (en) | 1998-02-05 |
JPH10500954A (ja) | 1998-01-27 |
US5545745A (en) | 1996-08-13 |
ATE195931T1 (de) | 2000-09-15 |
WO1995032178A1 (en) | 1995-11-30 |
PT763010E (pt) | 2000-12-29 |
GR3034982T3 (en) | 2001-02-28 |
JP3826208B2 (ja) | 2006-09-27 |
EP0763010A4 (en) | 1997-07-16 |
ES2151065T3 (es) | 2000-12-16 |
EP0763010B1 (en) | 2000-08-30 |
AU2555995A (en) | 1995-12-18 |
EP0763010A1 (en) | 1997-03-19 |
DE69518646D1 (de) | 2000-10-05 |
DE69518646T2 (de) | 2001-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0763010T3 (da) | Enantioselektiv præparering af optisk ren albuterol | |
DE69713374D1 (de) | Verfahren zur herstellung von optisch reinen isomeren des formoterols | |
DK1082293T3 (da) | Formoterol-polymorfer | |
KR870001142A (ko) | 페닐 에테르의 제법 | |
CY1110919T1 (el) | Μεθοδος για τον ενζυματικο διαχωρισμο εναντιομερων της 3(r)- kai 3(s)-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-1,2,3,6-τετραϋδρο-πυριδινης ή των εστερων καρβοξυλικου οξεος αυτης. | |
BR9506986A (pt) | Processo para a preparação de ácido (l) - ou (d) - homoalanin-4-il- (metil) fosfinico e seus sais por meio de separação de racematos | |
DK1418170T3 (da) | Fremgangsmåde til fremstilling af optisk aktive aminoalkohler ved racematspaltning | |
FI894022A0 (fi) | Menetelmä (2R,3S)-3-(4-metoksifenyyli)glysidiinihapon alemman alkyyliesterin valmistamiseksi | |
US5420329A (en) | Process for the preparation of L-phosphinothricin and its derivatives | |
CO4700282A1 (es) | Compuestos | |
ATE277015T1 (de) | Verfahren zur herstellung von 1,4-dihydropyridine sowie in diesem verfahren verwendete verbindungen | |
HU903056D0 (en) | Method for producing optically active ceramide type compounds | |
NO20001343L (no) | FremgangsmÕter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol | |
DK0625137T3 (da) | Fremgangsmåde til racematadskillelse af verapamil | |
CA2190577A1 (en) | Enantioselective preparation of optically pure albuterol | |
DK0801054T3 (da) | Fremgangsmåde til fremstilling af 2-(2-hydroxymethylphenyl)acetamidderivater og mellemprodukter til fremstilling deraf | |
ATE144519T1 (de) | Phosphinesterhaltige n-acyl-2-aminosäureamide, verfahren zu ihrer herstellung und n-acyl-2- aminosäurenitrile als vorprodukte | |
TW341559B (en) | Process for racemization of optically active 1-phenylethylamine derivative | |
DK0549710T3 (da) | Fremgangsmåde til fremstilling af enantiomere 2-alkansyrer | |
EP0808824A3 (en) | Process for preparing optically active 2-halogeno-3-hydroxypropionic acid ester | |
DE69803636D1 (de) | Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat | |
ATE212381T1 (de) | Optische trennung von alkyl 1,4-benzodioxan-2- carboxylaten mit einer esterase aus serratia marcescens | |
KR920012021A (ko) | (s)-비닐 및 -알레닐 gaba의 제조방법 | |
EP0795609A3 (en) | Process for preparing optically active trans-3-phenylglycidamide compounds | |
DE59803008D1 (de) | Verfahren zur Herstellung von Ethinylcyclopropan |